Systematic reviewindependent cross-checkabstract only checked★ key study I-DRY-04 in-depth review

Independent review: A1 milk may upset digestion, other effects unproven

Milk A1 β-casein and health-related outcomes in humans: a systematic review.

Overview

Küllenberg de Gaudry D et al.. Nutr Rev 2019 · PMID 30722004 · DOI 10.1093/nutrit/nuy063

Moderate certainty for digestive symptoms; low/very low for other outcomes.

Does the study support the specific claim? Partly · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

A1 casein and health.

How was the study done?

Systematic review with GRADE.

How many people, animals or samples were studied?

25 human studies.

What was actually found?

Digestive effects moderately supported; others not.

How large was the observed effect?

Not pooled.

What do the results mean in everyday life?

Some people may digest A2 milk better.

What are the study's limitations?

Small trials.

What does it say about Elawady's specific claim?

Partly supports C-DRY-07.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Systemic inflammation or disease.

Scientific in-depth review

1. Full reference

Authors
Küllenberg de Gaudry D et al.
Journal
Nutr Rev
Year
2019
Identifier
PMID 30722004 DOI 10.1093/nutrit/nuy063
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

COI not stated in PubMed record; publicly registered review (PROSPERO CRD42016043795); German academic authors (Cochrane Germany).

2. Research question

A1 beta-casein/BCM-7 and health outcomes in humans.

3. Study design and population

Study design
Systematic review – Systematic review with GRADE (RCTs, case-control, ecological studies).
Population

Humans in 15 RCTs, 2 case-control, 8 ecological studies

Country

Multinational

Period

Search to Oct 2017

Sample size

25 studies

Inclusion and exclusion criteria

Predefined; A1 or BCM-7 exposure in humans.

4. Methods and endpoints

Exposure / intervention

A1 beta-casein / BCM-7

Comparator

A2 milk or none

Endpoints

Any health-related outcome.

Statistical methods

Narrative synthesis with GRADE.

5. Actual results

Results

Most RCTs and case-control studies on intermediate markers found no significant difference between milk types; most ecological studies reported adverse associations; certainty moderate for digestive symptoms, low to very low for all other outcomes.

Absolute risks

not applicable

Authors' conclusion

Moderate certainty for adverse digestive effects of A1 vs A2; low or very low certainty for other effects.

6. Strengths

  • Registered protocol, dual extraction, GRADE
  • Independent academic team

7. Weaknesses

  • Few, small, often industry-funded primary trials
  • Ecological data weak

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

Well-conducted review; primary evidence limited.

9. Assessment of the statistical interpretation

Qualitative; GRADE-based.

10. Relevance to the specific claim

Mixed for C-DRY-07; limiting for C-DRY-10.

11. Independent contrary findings

n/a

12. Transferability to Germany and Europe

High (academic European review).

13. Overall methodological judgement

Best independent synthesis: digestive effects plausible, other claims weak.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultsnot applicable
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Independent large RCTs.

15. Linked fact checks